SDGR FY2025 SEC EDGAR DEF 14A #119 of 168 in industry

Schrodinger, Inc. CEO pay ratio

The CEO earned $4.1M in FY2025 against median worker pay of $179,327 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-28
Industry
Chemicals & Pharmaceuticals
Industry rank
#119/168

Data updated August 2026

Subscribe to Schrodinger, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
23:1
Below Average (Scale: 0–1000:1)
CEO pay
$4.1M
Median worker
$179,327

Answer first

Schrodinger, Inc.'s FY2025 CEO total of $4.1M ranks #994 of 1,423 complete filings; its 23:1 pay ratio ranks #1187. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $179,327. Industry placement uses the FY2025 SIC-28 peer cohort (# 119 of 168, 30th percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#994
$4.1M of 1,423 FY2025
Ratio rank
#1187
23:1 of 1,423
Industry pct
30th
below the industry median pay ratio

How Schrodinger, Inc. ranks nationally

Schrodinger, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$4,124,521 30th percentile higher than 30% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). This entry sits in this band. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Schrodinger, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($4.1M) against pay ratio (23:1) for Schrodinger, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both1865727.84015392.96165058.08314723.110464388.222.1:127.3:132.5:137.7:143.0:1CEO total payPay ratio (CEO : median worker)Schrodinger, Inc., CEO total pay: 4124521 · Pay ratio (CEO : median worker): 23:1Schrodinger, Inc.Kronos Worldwide Inc, CEO total pay: 2256576 · Pay ratio (CEO : median worker): 23:1Kronos Worldwide IncTravere Therapeutics, Inc., CEO total pay: 8457151 · Pay ratio (CEO : median worker): 23:1Travere Therapeutics, Inc.Nurix Therapeutics, Inc., CEO total pay: 6307796 · Pay ratio (CEO : median worker): 23:1Nurix Therapeutics, Inc.Axsome Therapeutics, Inc., CEO total pay: 10073540 · Pay ratio (CEO : median worker): 23:1Axsome Therapeutics, Inc.Praxis Precision Medicines, Inc., CEO total pay: 8708648 · Pay ratio (CEO : median worker): 23:1Praxis Precision Medicines, Inc.
Schrodinger, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Schrodinger, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Schrodinger, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
23:1
FY2025
vs prior FY
-3:1
from FY2024 26:1
CEO $ YoY
-7.3%
$4.1M latest
Filings shown
4
FY2022–2025
Schrodinger, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $3.9M - $178,089 22:1 -
2023 $3.2M -18% $159,737 20:1 -2:1
2024 $4.5M +39% $171,183 26:1 +6:1
2025 $4.1M -7.3% $179,327 23:1 -3:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1490978, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
23:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$4.1M
Companies in Industry
168
vs. Industry Median
Below
#119 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Schrodinger, Inc.: near-parity Item 402(u) ratio

Schrodinger, Inc.'s FY2025 ratio 23:1 ranks #119 of 168 Chemicals & Pharmaceuticals filers (30th percentile). the CEO earned 23× the median employee ($179,327) in FY2025.

At $179,327 median worker pay, the FLOOR stamp is near pay-parity territory under MID$ CEO total.

CEO Total Pay

$4.1M

FY2025 Summary Compensation, below median

Pay Ratio

23:1

Below typical

Schrodinger, Inc. in the lower Chemicals & Pharmaceuticals third

Schrodinger, Inc.'s FY2025 ratio 23:1 ranks #119 of 168 Chemicals & Pharmaceuticals filers (30th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Schrodinger, Inc.'s $4.1M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #994 and ratio rank #1187 split - treat 23:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$4.1M
Median Employee Pay
$179,327
Pay Ratio
23:1
Filing Date
2026-04-28

Company Info

Ticker
SDGR
CIK
1490978
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1490978, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Schrodinger, Inc.'s FY2025 ratio 23:1 ranks #119 of 168 Chemicals & Pharmaceuticals filers (30th percentile).

Read with Schrodinger, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MID$ · ELITE-MED.

Entravision Communications Corp · MID$

ABS(ceo_total_comp) peer at $4.1M (Δ $479 heavier vs Schrodinger, Inc.); MID · PAR-MED vs this page's FLOOR · MID$ · ELITE-MED.
ChargePoint Holdings, Inc. · MID$

ABS(ceo_total_comp) peer at $4.1M (Δ $12K lighter vs Schrodinger, Inc.); MODEST · HIGH-MED vs this page's FLOOR · MID$ · ELITE-MED.
Caleres Inc · MID$

ABS(ceo_total_comp) peer at $4.1M (Δ $19K heavier vs Schrodinger, Inc.); STEEP · LOW-MED vs this page's FLOOR · MID$ · ELITE-MED.
NUSCALE POWER Corp · MID$

ABS(ceo_total_comp) peer at $4.1M (Δ $23K heavier vs Schrodinger, Inc.); FLOOR · ELITE-MED vs this page's FLOOR · MID$ · ELITE-MED.
Kronos Worldwide Inc (SIC 28 pole)

Kronos Worldwide Inc stamps FLOOR · MID$ nearest in-SIC by ABS(pay_ratio) to Schrodinger, Inc.'s FLOOR filing.
National dual ranks · #994/#1187

Schrodinger, Inc.'s FY2025 package sits #994 by CEO dollars and #1187 by ratio under MID$ · FLOOR.
Ratio primer · FLOOR

Schrodinger, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Schrodinger, Inc. (CIK 1490978), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.